E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases

E10A, a replication-defective adenovirus carrying human endostatin gene, has finished Phase I clinical trials for solid cancers. We assessed whether the combination of E10A with docetaxel would enhance antiangiogenic activities and inhibit prostate cancer growth and metastases. Combination use of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Peng, Luo, Rongcheng, Wu, Jiangxue, Xie, Fajun, Li, Hongli, Xiao, Xia, Fu, Liwu, Zhu, Xiaofeng, Liu, Ranyi, Zhu, Yinghui, Liang, Zhihui, Huang, Wenlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837610/
https://www.ncbi.nlm.nih.gov/pubmed/26065034
http://dx.doi.org/10.1111/j.1582-4934.2008.00548.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837610/
https://www.ncbi.nlm.nih.gov/pubmed/26065034
http://dx.doi.org/10.1111/j.1582-4934.2008.00548.x

Ejemplares similares